NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/10/2026
Back to search
Official data from USPTO
TOPO THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TOPO THERAPEUTICS
ST13
US500000098977477Class
42
Filing
98977477
Registration
8139101
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
02/11/2026
Trademark type
Word
Nice classes
42
Filing date
07/15/2024
Registration date
02/10/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/10/2026
Last transaction
02/11/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/17/2024
First use in commerce
09/17/2024
Drawing code
4
Owner type
03
Owner location
Watertown, MA
Examiner
HARMON, RAYMOND E
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Topo Therapeutics, Inc.
Topo Therapeutics, Inc.
Representatives
Susan Weller Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and pharmaceutical research services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific researchconducting clinical trials for others; laboratory research services relating to pharmaceuticals; scientific and technological servicesresearch and design services in the field of process developmentvalidationqualificationmanufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological services consultation services in the field of developmentmanufacturing and testing of pharmaceuticals and biopharmaceuticals; providing product research and development in the pharmaceutical field for purposes of process developmentvalidationqualificationmanufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological consultation services in the field of pharmaceutical research and pharmacology; custom development of pharmaceuticalbiopharmaceutical and chemical products; pre-clinical and non-clinical evaluation testing of pharmaceuticalbiopharmaceutical and chemical products performed primarily using animals and other biological models; pharmaceuticalbiopharmaceuticalchemical research and development for others; pharmaceutical research for the purpose of treating pain disordersfolding disorderssecretory diarrhea; pharmaceutical research for use in pediatricgeriatricemergencyfamilypreventative medicine
Publications
History of USPTO decisions and trademark events.
44 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/10/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/22/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/22/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/22/2026
DPCC
DIVISIONAL PROCESSING COMPLETE
01/22/2026
IUAF
USE AMENDMENT FILED
01/21/2026
DRRR
DIVISIONAL REQUEST RECEIVED
01/21/2026
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
01/21/2026
EISU
TEAS STATEMENT OF USE RECEIVED
01/21/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/09/2026
EX1G
SOU EXTENSION 1 GRANTED
01/08/2026
EXT1
SOU EXTENSION 1 FILED
01/08/2026
EEXT
SOU TEAS EXTENSION RECEIVED
01/08/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/20/2025
CORV
REVIEW OF CORRESPONDENCE COMPLETE
11/19/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/19/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/18/2025
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
09/18/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/12/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/12/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/12/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/12/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
07/06/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
03/26/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/25/2025
PUBO
PUBLISHED FOR OPPOSITION
02/25/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/30/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
01/30/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/30/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
01/30/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/30/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/29/2025
GNRT
NON-FINAL ACTION E-MAILED
01/29/2025
CNRT
NON-FINAL ACTION WRITTEN
01/29/2025
DOCK
ASSIGNED TO EXAMINER
01/28/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/15/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/21/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/21/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/21/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/21/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/21/2024
NWAP
NEW APPLICATION ENTERED
07/15/2024
Continuous trademark protection
Get notified about every new filing that threatens TOPO THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.